This type of modeling is sometimes called a computer-aided drug design. Ultimately, drug formation based on the knowledge of the three-dimensional structure of a biomolecular target is known as the drug-based structure. In addition to small molecules, biopharmaceuticals including peptides and in particular therapeutic antibodies are an increasingly important class of drugs and combinations to promote the synthesis, selectivity, and stability of these protein-based therapies. Drug designation, often referred to as rational drug design or rational design, is the process of designing a new drug based on biological information. The drug is often a small organ molecule that stimulates or inhibits the activation of a protein-like biomolecule, which is also a therapeutic benefit for the patient. In a very basic sense, drug formation involves the formation of conformational molecules and charges at the biomolecular target in which they interact and will therefore bind to it. The design of drugs is often but does not depend on computer modeling.